CRISPR Nobel Prize Winners Beat European Patent Challenge
The European Patent Office's Opposition Division has refused to invalidate a Nobel Prize-winning team's patent for the gene-editing technology CRISPR-Cas9, a licensee announced Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article